2022
DOI: 10.1016/j.jebdp.2022.101777
|View full text |Cite
|
Sign up to set email alerts
|

Use of Mouthwash and Dentifrice Containing an Antimicrobial Phthalocyanine Derivative for the Reduction of Clinical Symptoms of Covid-19: A Randomized Triple-Blind Clinical Trial

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…After the title and abstract screening, the duplicates were removed, and 50 articles remained for full-text analysis. After full-text analysis, 36 were eliminated: 6 for not being a randomized trial [ 44 , 45 , 46 , 47 ], 3 for being an in vitro study [ 48 , 49 , 50 ], 17 for not having quantitative data of viral load [ 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 ], 3 for not being in the oral cavity [ 68 , 69 , 70 ], 5 for not being a mouth rinse [ 71 , 72 , 73 , 74 , 75 ], and 2 for being a summary protocol [ 76 , 77 ]. Finally, 14 articles were selected for data extraction [ 12 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ,…”
Section: Resultsmentioning
confidence: 99%
“…After the title and abstract screening, the duplicates were removed, and 50 articles remained for full-text analysis. After full-text analysis, 36 were eliminated: 6 for not being a randomized trial [ 44 , 45 , 46 , 47 ], 3 for being an in vitro study [ 48 , 49 , 50 ], 17 for not having quantitative data of viral load [ 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 ], 3 for not being in the oral cavity [ 68 , 69 , 70 ], 5 for not being a mouth rinse [ 71 , 72 , 73 , 74 , 75 ], and 2 for being a summary protocol [ 76 , 77 ]. Finally, 14 articles were selected for data extraction [ 12 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ,…”
Section: Resultsmentioning
confidence: 99%
“…The Centers for Disease Control and Prevention (CDC) has advocated the benefits of preprocedural mouthwashes in reducing airborne pathogens of all types before clinical procedures [ 28 ]. Studies by Bernardo da Fonseca Orcina [ 29 ] and Marcelo Lupion Poleti et al [ 30 ] indicated that mouthwashes containing antimicrobial phthalocyanine derivative (APD) had been found to have a positive impact on the relief of early clinical symptoms of patients with COVID-19, such as sore throat, cough, and mouth ulcers.…”
Section: Discussionmentioning
confidence: 99%